Prognostic factors for death after surgery for small intestinal neuroendocrine tumours
Open Access
- 28 May 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 2 (5) , 345-352
Abstract
Background Neuroendocrine tumours of the small intestine (SI‐NETs) are rare gastrointestinal neoplasms with an annual incidence of about one per 100 000. Patients with apparently similar tumours have variable outcomes. The aim of this study was to identify postoperative prognostic factors identifiable after initial surgery. Methods This was a nested case–control study of patients with SI‐NETs who were treated between 1961 and 2001. Data were retrieved from the Swedish Cancer Registry. Patients who died from the SI‐NET and corresponding controls (who outlived cases by at least 1 month), matched by age at diagnosis and calendar period, were included. Sex, postoperative symptoms, postoperative 5‐hydroxyindoleacetic acid (5‐HIAA) values, European Neuroendocrine Tumor Society (ENETS) stage, insufficiency of the tricuspid valve, radical secondary surgery and secondary malignancy were studied as potential prognostic factors. Results In total, 1122 patients were included (561 cases, 561 controls). Postoperative factors of prognostic importance included hormone‐related symptoms, stage IV disease, raised levels of 5‐HIAA, insufficiency of the tricuspid valve, secondary surgery not being macroscopically radical and a second malignancy. Conclusion Stage and symptomatic disease are important prognostic factors in SI‐NET.Keywords
Funding Information
- Bengt Ihre Foundation
- Bergholm/Eriksson Foundation
- Ipsen Innovation
This publication has 33 references indexed in Scilit:
- Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumoursBritish Journal of Surgery, 2013
- The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine TumorsPancreas, 2010
- Midgut neuroendocrine tumours with liver metastases: results of the UKINETS studyEndocrine-Related Cancer, 2009
- Survival and Prognostic Factor Analysis of 146 Metastatic Neuroendocrine Tumors of the Mid-GutNeuroendocrinology, 2009
- Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumoursEndocrine-Related Cancer, 2008
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Prognosis of Carcinoid Heart DiseaseCirculation, 2005
- Management of midgut carcinoidsJournal of Surgical Oncology, 2005
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Completeness of the Swedish Cancer Register Non-Notified Cancer Cases Recorded on Death Certificates in 1978Acta Radiologica: Oncology, 1984